Immunocore (NASDAQ:IMCR) Downgraded to Neutral at Guggenheim

Written by MarketBeatOctober 7, 2024 ShareLink copied to clipboard. Immunocore (NASDAQ:IMCR - Get Free Report) was downgraded by Guggenheim from a "buy" rating to a "neutral" rating in a report released on Monday, Briefing.com reports.Get I
Read more...